Failed Fed study on Indapamide MR [Study As­sess­ment]

posted by ElMaestro  – Denmark, 2013-11-19 16:56 (4600 d 16:15 ago) – Posting: # 11915
Views: 14,635

Hello Clarc,

I get a 26% CV for AUC, which is a bit higher than the observed CV for Cmax. Although this may happen, it is rarely the actual case and for that reason I raise an eyebrow. So I can't conclude anything, but I would investigate this if I were you; in particular I'd look at the raw data from the bioanalysis, esp. chromatograms.
In the past when I have triggered audits because of this phenomenon we have always been able to identify an 'issue' although in the grand scheme of things it has not been that many studies, and none of them were MR SODFs if I recall correctly.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
137 visitors (0 registered, 137 guests [including 21 identified bots]).
Forum time: 10:12 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5